|
|
40
|
|
|
1642X
|
|
|
HALOPERIDOL 5MG/ML INJ (MON/PHA)
|
|
|
HALOPERIDOL
|
|
|
HALOPERIDOL
|
|
|
10X1ML
|
|
|
B
|
|
|
6.20
|
|
|
0.62
|
|
|
5MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
AMP
|
|
|
MON
|
|
|
MONTAGE PHARMACEUTICALS
|
|
|
PHA
|
|
|
PHARMACY SALES CARIBBEAN
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
28160808
|
|
|
BUTYROPHENES
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|